Abbott Laboratories
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $9.63B
| Line Item | Value | % of Total |
|---|---|---|
| Dividends Paid | $2.48B | 25.8% |
| Stock Repurchases | $65.0M | 0.7% |
| Net Change in Short-Term Borrowings | $1.66B | 17.2% |
| Other Financing | $1.22B | 12.7% |
| Other | $1.04B | 10.8% |
| Net Cash Flow | $3.17B | 32.9% |